ABVC MEXC RealStocks
Own real ABVC shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-18 07:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ABVC BioPharma, Inc. (ABVC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.94, with a market capitalization of $25.36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.71 to $2.96. This page covers its latest market performance, valuation, price trends and company information.
$25.36M | |
$0.99 | |
$1.00 | |
$0.91 | |
$0.94 | |
23.69K | |
82.78K | |
-- | |
$2.96 | |
$0.71 | |
-- | |
-- |
ABVC BioPharma, Inc. (ABVC) last closed at $0.94 as of 2026-11-18 00:05:00, down 2.29% ($0.02) from the previous close of $0.94.
During the latest regular trading session, ABVC traded between $0.91 and $1.00, with a volume of 23.69K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, ABVC BioPharma, Inc. (ABVC) moved from $1.02 to $0.94, representing a decline of 7.55% ($0.08).
The stock traded between $0.86 and $1.08 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 30.37 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 10.5%
ABVC is currently trading at $0.94, placing it 10.5% of the way from its 52-week low of $0.71 to its 52-week high of $2.96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 19 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ABVC BioPharma, Inc. (ABVC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ABVC, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ABVC shares and USD.
ABVC Shares to USD
1.00 ABVC shares = 0.943 USD
Calculations are estimates based on the latest available price and are for reference only.